Misook Yu

Array ( [id] => 1312747 [patent_doc_number] => 06613882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-02 [patent_title] => 'Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest' [patent_app_type] => B1 [patent_app_number] => 09/484471 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6615 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613882.pdf [firstpage_image] =>[orig_patent_app_number] => 09484471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245529 [patent_doc_number] => 06677128 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum' [patent_app_type] => B1 [patent_app_number] => 09/464840 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6715 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677128.pdf [firstpage_image] =>[orig_patent_app_number] => 09464840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 526362 [patent_doc_number] => 07183251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-02-27 [patent_title] => 'hCG therapy for the treatment of breast cancer' [patent_app_type] => utility [patent_app_number] => 09/868196 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 11728 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183251.pdf [firstpage_image] =>[orig_patent_app_number] => 09868196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938300 [patent_doc_number] => 06972128 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-06 [patent_title] => 'Use of human prostrate cell lines in prostate cancer treatment' [patent_app_type] => utility [patent_app_number] => 09/857691 [patent_app_country] => US [patent_app_date] => 1999-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 4840 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972128.pdf [firstpage_image] =>[orig_patent_app_number] => 09857691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202522 [patent_doc_number] => 06720159 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => '88KDA tumorigenic growth factor and antagonists' [patent_app_type] => B1 [patent_app_number] => 09/456886 [patent_app_country] => US [patent_app_date] => 1999-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 25184 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720159.pdf [firstpage_image] =>[orig_patent_app_number] => 09456886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1110681 [patent_doc_number] => 06806071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Glutathione S-transferase' [patent_app_type] => B1 [patent_app_number] => 09/441723 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19755 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806071.pdf [firstpage_image] =>[orig_patent_app_number] => 09441723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793276 [patent_doc_number] => 06982322 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-03 [patent_title] => 'Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip' [patent_app_type] => utility [patent_app_number] => 09/830338 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5898 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982322.pdf [firstpage_image] =>[orig_patent_app_number] => 09830338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043747 [patent_doc_number] => 06867180 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth' [patent_app_type] => utility [patent_app_number] => 09/807148 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 19951 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867180.pdf [firstpage_image] =>[orig_patent_app_number] => 09807148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 742008 [patent_doc_number] => 07030231 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-18 [patent_title] => 'Membrane type serine protease 1 (MT-SP1) and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/410362 [patent_app_country] => US [patent_app_date] => 1999-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 36451 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030231.pdf [firstpage_image] =>[orig_patent_app_number] => 09410362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 485927 [patent_doc_number] => 07217686 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-15 [patent_title] => 'DNA sequence encoding oncofetal ferritin protein' [patent_app_type] => utility [patent_app_number] => 09/786867 [patent_app_country] => US [patent_app_date] => 1999-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 12153 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217686.pdf [firstpage_image] =>[orig_patent_app_number] => 09786867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 479257 [patent_doc_number] => 07223850 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-29 [patent_title] => 'Apoptosis proteins' [patent_app_type] => utility [patent_app_number] => 09/762491 [patent_app_country] => US [patent_app_date] => 1999-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 22640 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223850.pdf [firstpage_image] =>[orig_patent_app_number] => 09762491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680601 [patent_doc_number] => 07084249 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-01 [patent_title] => 'Tumor associated antigen peptides and use of same as anti-tumor vaccines' [patent_app_type] => utility [patent_app_number] => 09/744804 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 20769 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084249.pdf [firstpage_image] =>[orig_patent_app_number] => 09744804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985066 [patent_doc_number] => 20020098171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'NEW APPLICATION OF LYSOZYME DIMER' [patent_app_type] => new [patent_app_number] => 09/348814 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10815 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098171.pdf [firstpage_image] =>[orig_patent_app_number] => 09348814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727417 [patent_doc_number] => 07041297 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-09 [patent_title] => 'Tumor antigen peptides originating in cyclophilin B' [patent_app_type] => utility [patent_app_number] => 09/720469 [patent_app_country] => US [patent_app_date] => 1999-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15944 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041297.pdf [firstpage_image] =>[orig_patent_app_number] => 09720469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065786 [patent_doc_number] => 06846912 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Antibody against LAR phosphatase subunit' [patent_app_type] => utility [patent_app_number] => 09/719272 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15435 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846912.pdf [firstpage_image] =>[orig_patent_app_number] => 09719272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388054 [patent_doc_number] => 06544749 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Antibodies to leukemia inhibitory factor and their use in immunoassays' [patent_app_type] => B1 [patent_app_number] => 09/321935 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6577 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544749.pdf [firstpage_image] =>[orig_patent_app_number] => 09321935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1174473 [patent_doc_number] => 06750330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Lyophilized tubulins' [patent_app_type] => B1 [patent_app_number] => 09/310981 [patent_app_country] => US [patent_app_date] => 1999-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8277 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750330.pdf [firstpage_image] =>[orig_patent_app_number] => 09310981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017822 [patent_doc_number] => 06890716 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Recombinant cell line and screening method for identifying agents which regulate apoptosis and tumor suppression' [patent_app_type] => utility [patent_app_number] => 09/674876 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 40 [patent_no_of_words] => 23124 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890716.pdf [firstpage_image] =>[orig_patent_app_number] => 09674876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 694232 [patent_doc_number] => 07070954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Isolated SH3 genes associates with myeloproliferative disorders and leukemia and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/720934 [patent_app_country] => US [patent_app_date] => 1999-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 18 [patent_no_of_words] => 19630 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070954.pdf [firstpage_image] =>[orig_patent_app_number] => 09720934 [rel_patent_id] =>[rel_patent_doc_number] =>)